Prognostic understanding and quality of life in patients with advanced lung cancer : a multicenter study by Janssens, Annelies et al.
Original StudyPrognostic Understanding and Quality of Life in
Patients With Advanced Lung Cancer: A
Multicenter Study
Annelies Janssens,1 Soﬁa Derijcke,2 Daniëlle Galdermans,3 Marc Daenen,4
Veerle Surmont,5 Els De Droogh,3 Anneke Lefebure,6 Erika Saenen,7
Elke Vandenbroucke,8 Ann-Marie Morel,9 Anna Sadowska,10
Jan P. van Meerbeeck1
Abstract
Communication about the palliative setting remains difﬁcult for many physicians. This seems a valid concern.
Our study has shown that prognostic understanding will be associated with poorer emotional well-being and
more pain but not with a worse mood. A poor mood has a detrimental effect on all aspects of quality of life. Our
data suggest the need for psychological support, in addition to communication about the palliative setting.
Introduction: Communication about the palliative setting remains a barrier for many physicians because they are
afraid to harm the patient by giving bad news. We sought to determine whether this a valid concern; the inﬂuence of
prognostic understanding on patients’ quality of life (QoL); and which factors inﬂuence this relationship.Methods: The
present multicenter, cross-sectional study used a questionnaire to measure patients’ prognostic understanding, QoL,
mood, and coping strategy. Results:We surveyed 125 patients with advanced lung cancer. Prognostic understanding
correlated signiﬁcantly with emotional well-being (r ¼ 0.20; P ¼ .01) and pain (r ¼ 0.43; P ¼ .00) but not with anxiety
(r ¼ 0.12, P ¼ .12) or depression (r ¼ 0.05; P ¼ .29). Patients with anxiety (r ¼ 0.23; P ¼ .01) and patients with
depressive feelings (r ¼ 0.63; P ¼ .00) experienced poorer QoL. Four in 10 patients reported feelings of anxiety and/
or depression. Positive reframing as a coping strategy was associated with a better QoL (r ¼ 0.25; P ¼ .00).
Conclusion: Prognostic understanding was related to poorer emotional well-being and more pain but does not affect
mood. Four in 10 patients reported feelings of anxiety and/or depression, which were associated with a poorer QoL. A
holistic approach seems necessary when physicians communicate about the palliative setting.
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Advanced lung cancer is associated with a poor prognosis and a
median survival ofw10 months, which implies the use of palliative
treatment from the diagnosis.1 In the palliative setting, patients will
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Prognostic Understanding and QoL in Advanced Lung Cancerthat the proposed treatment is unlikely to be curative to obtain
prognostic understanding.3 This allows for shared decision-making
and leads to “the right therapy for the right patient at the right
time,” enabling personalized treatment.4
Patients’ QoL is key in the treatment of patients with advanced
lung cancer, and it is important to inform patients regarding the
palliative intent of their treatment. It remains uncertain, however,
whether patients’ prognostic understanding inﬂuences QoL and
whether their mood and the use of coping strategies play a role in
this relationship. Some investigators have reported a possible
detrimental effect of prognostic understanding on patients’ QoL5-7
and reported that prognostic understanding will lead to anxiety and/
or depression, with lower QoL ensuing as a result. It has been
suggested that adding psychological support to early palliative care,
thus enhancing favorable coping strategies, would buffer this effect
(Figure 1).
Methods
We conducted a multicenter cross-sectional study in 10 hospitals
in Flanders, Belgium: Antwerp University Hospital, AZ Groeninge
Kortrijk, ZNA Sint-Erasmus Borgerhout, AZ Monica Deurne, Sint-
Jozef Kliniek Bornem and Willebroek, Ghent University Hospital,
ZNA Middelheim Antwerp, Heilige Familie Reet, Ziekenhuis Oost
Limburg, and Ziekenhuis Maas en Kempen, Maaseik. The ethical
committee of all the hospitals approved the present study.
Patients with advanced lung cancer at any time in the disease
trajectory were eligible for inclusion in the present study if they were
aged >18 years and were able to read and write in Dutch. After the
patients had provided written informed consent, the treating
physician asked the patients to complete the questionnaires, either
when visiting the outpatient clinic or during hospitalization. The
following data were obtained: age, gender, marital status, religion,
date of diagnosis, and World Health Organization performance
status.8
Prognostic understanding was evaluated using the patients’
responses to the statements “I can be cured” and “My treatment can
cure me” on a 4-point Likert scale ranging from “very likely” to “not
at all likely.” Previous research has shown that prognostic under-
standing measured using this method is valid and reliable.3 We also
used the QLQ-C15-PAL, a shortened version of the European
Organization for the Research and Treatment of Cancer QLQ-C30,
a widely used instrument for measuring QoL in cancer research.9
The QLQ-C15-PAL questionnaire contains 4 multi-item scalesFigure 1 Relationship Between Prognostic Understanding,
Mood, Coping and QoL
- Clinical Lung Cancer May 2019and 6 individual items that have been identiﬁed as important in the
palliative population. All items are rated from 1 (not at all) to 4
(very much) in severity, except for the overall QoL scale, which is
rated from 1 (very poor) to 7 (excellent). A high score on the
symptom scale suggests increased distress, and a high score on the
functional scale shows increased functional ability. Each scale was
converted to a score ranging from 0 to 100.
Anxiety and depression were measured using the Hospital Anx-
iety and Depression Scale (HADS), which consists of 14 items: 7
items on the anxiety subscale (HADS Anxiety) and 7 on the
depression subscale (HADS Depression). The HADS Anxiety scale
focuses mainly on the symptoms of generalized anxiety disorder and
the HADS Depression scale focuses on anhedonia, the main
symptom of depression.10 Each item is scored on a response scale
with 4 alternatives, ranging from 0 to 3. After adjusting for 6 items
that are reverse scored, all responses were summed to obtain the 2
subscales. The cutoff scores recommended by Zigmond and
Snaith11 are 8 to 10 for doubtful cases and 11 for deﬁnite cases.
An optimal balance between sensitivity and speciﬁcity has been
found using a cutoff score of 8 for both the HADS Anxiety and the
HADS Depression scales.
The use of coping strategies was assessed using the brief COPE
(Coping Orientation for Problem Experiences) questionnaire.12 We
incorporated 6 coping strategies that are considered highly relevant
to patients with incurable cancer7: emotional support, positive
reframing, active coping, acceptance, self-blame, and denial. The
developer of the instrument has encouraged such selective and
ﬂexible use of the subscales. Participants select the degree to which
they have used each type of coping (1, not at all; 2, a little bit; 3, a
medium amount; and 4, a lot).
Statistical Analysis
All data were collected and encoded in an SPSS database (SPSS
statistics, version 24; IBM Corp, Armonk, NY) by the principal
investigator. A sum score was calculated for all scales, with the
median, standard deviation, and Cronbach’s a. The data were
analyzed using descriptive statistics. Pearson’s correlation coefﬁcient
or regression analysis and multiple hierarchical regression analysis
were used to determine the relationships between the different
parameters. The results were considered signiﬁcant at P ¼ .05. To
determine whether the coping strategy had a moderating effect on
the relationship between prognostic understanding and QoL, the
interaction term between prognostic understanding and coping
strategy was added to a multiple regression model.13
Results
The trial included 125 patients from 10 hospitals and the studio
period was from May 1 to June 31, 2017. We asked a total of 128
patients to participate. Three patients were not willing to complete
the questionnaire: 1 was too tired, 1 reported being tired of
completing questionnaires, and 1 did not give a reason. The soci-
odemographic characteristics of all the patients are listed in Table 1.
The range, number of items, mean, standard deviation, and
Cronbach’s a of the prognostic understanding, mood, and coping
strategy are listed in Table 2. The mean value for prognostic
understanding was 2.9. Of the 125 patients, 47% were aware of the
incurability of their lung cancer. Of these, 33% showed prognostic
Table 1 Demographic Characteristics
Variable Value
Age, y
Median 65
Range 41-85
Interval from diagnosis, mo
Median 12
Range 1-88
Gender, n (%)
Male 75 (60)
Female 50 (40)
WHO grade, n (%)
0 23 (19)
1 47 (56)
2 35 (28)
3 18 (15)
Marital status
Married 85 (69)
Unmarried 11 (9)
Divorced 18 (15)
Widow(er) 10 (8)
Religious
Yes 65 (59)
No 45 (41)
Children
Yes 113 (91)
No 11 (9)
Abbreviation: WHO ¼ World Health Organization.
Annelies Janssens et alunderstanding, meaning that they were also aware that their treat-
ment was not meant to cure them. The median interval from
diagnosis was 12 months (range, 1-88 months). Prognostic under-
standing correlated signiﬁcantly with the interval from diagnosis
(r ¼ 0.34; P ¼ .00). Emotional well-being did not correlate
signiﬁcantly with the interval from diagnosis (r ¼ 0.16; P ¼ .1).
The longer the interval from the diagnosis with lung cancer, the
better the patients’ prognostic understanding. However, the interval
from the diagnosis did not correlate with the patients’ emotional
well-being.Table 2 Range, Number of Items, Mean, Standard Deviation, and C
Variable Range Items, n
Prognostic understanding 1-4 2
Anxiety 0-21 7
Depression 0-18 7
Acceptance 0-4 2
Denial 0-4 2
Active coping 0-4 2
Emotional support 0-4 2
Positive reframing 0-4 2
Self-blame 0-4 2
Abbreviation: SD ¼ standard deviation.In our study, 1 in 4 patients were experiencing anxiety or
depression. Of our 125 patients, 20% and 26% had mild
complaints related to anxiety or depression, 11% and 10% had
moderate complaints, and 4% and 2% were severely anxious or
severely depressed (Table 3). The range, number of items, mean,
standard deviation, and Cronbach’s a for the various dimensions of
QoL are presented in Table 4. These dimensions are explored in
more depth in the subsequent paragraphs in relation to the results
presented in Table 5.
The correlations between prognostic understanding and the
different aspects of QoL are presented in Table 5. Emotional
well-being signiﬁcantly and negatively correlated with prognostic
understanding (r ¼ 0.20; P < .05) and with pain (r ¼ 0.22;
P < .05). No other signiﬁcant correlations were observed between
prognostic understanding and the other aspects of QoL.
The correlations between mood and QoL are also listed in
Table 5. Anxiety correlated signiﬁcantly with general QoL
(r ¼ 0.23; P < .05), physical well-being (r ¼ 0.21; P < .05),
emotional well-being (r ¼ 0.44; P < .01), pain (r ¼ 0.46;
P < . 01), dyspnea (r ¼ 0.21; P < .05), insomnia (r ¼ 0.38;
P < .01), and constipation (r ¼ 0.21; P < .05). Depression
correlated signiﬁcantly with general QoL (r ¼ 0.63; P < .01),
physical well-being (r ¼ 0.44; P < .01), emotional well-being
(r ¼ 0.73; P < .01), pain (r ¼ 0.37; P < .01), fatigue
(r ¼ 0.49; P < .01), dyspnea (r ¼ 0.44; P < .01), insomnia
(r ¼ 0.20; P < .01), loss of appetite (r ¼ 0.45; P < .01), nausea
(r ¼ 0.29; P < .01), and constipation (r ¼ 0.27; P < .01).
The correlations between the use of coping strategies and QoL
are also presented in Table 5. Positive reframing correlated signiﬁ-
cantly with general QoL (r ¼ 0.25; P < .01), emotional
well-being (r ¼ 0.33; P < .01), pain (r ¼ 0.30; P < .01),
fatigue (r ¼ 0.22; P < .01), loss of appetite (r ¼ 0.22; P < .01),
and nausea (r ¼ 0.24; P < .01). Emotional coping correlated
signiﬁcantly with physical well-being (r ¼ 0.20; P < .05). Self-
blame correlated signiﬁcantly with emotional well-being
(r ¼ 0.19; P < .05) and insomnia (r ¼ 0.19; P < .05).
A 2-stage hierarchical multiple regression analysis was conducted
to investigate whether the use of coping strategies moderates the
relationship between prognostic understanding and emotional well-
being. In the ﬁrst step, the standardized scores of the sum scales for
prognostic understanding, acceptance, active coping, emotional
support, self-blame, positive reframing, and denial wereronbach’s a
Mean SD Cronbach’s a
2.9 1.01 0.92
6.5 4.1 0.81
6.4 3.6 0.72
3.0 0.75 0.69
1.8 0.89 0.78
2.3 0.60 0.81
3.5 0.66 0.89
2.5 0.84 0.69
1.7 0.85 0.79
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Table 3 Percentage of Patients With Normal, Mild, Moderate,
and Severe Complaints
HADS Score Anxiety, % Depression, %
0-7 (normal) 65 62
8-10 (mild) 20 26
11-14 (moderate) 11 10
>14 (severe) 4 2
Abbreviation: HADS ¼ Hospital Anxiety and Depression Scale.
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being was added as an independent variable. Model 1 showed sta-
tistically signiﬁcant results [F(6,105) ¼ 4.0; P < .01]. The vari-
ability was 23% (R2 ¼ 0.23). No signiﬁcant correlation was found
between prognostic understanding and emotional well-being (P ¼
.34). Acceptance (b ¼ 0.21; P ¼ .03) and positive reframing were
signiﬁcantly related to emotional well-being. In the second step, the
following interaction terms were added: prognostic under-
standing*acceptance, prognostic understanding*active coping,
prognostic understanding*emotional support, prognostic
understanding*self-blame, prognostic understanding*positive
reframing, and prognostic understanding*denial. The results from
model 2 were not signiﬁcant [F(12,99) ¼ 1.5; P ¼ .21]. The
variability was 28% (R2 ¼ 0.28). None of the interaction terms was
found to be signiﬁcant. The present study showed no statistically
signiﬁcant correlations between prognostic understanding and
anxiety (r ¼ 0.12; P ¼ .12) or depression (r ¼ 0.05; P ¼ .05).
Discussion
To the best of our knowledge, the present study is the ﬁrst
European study to investigate the relationship between prognostic
understanding and QoL in patients with advanced lung cancer. Our
results showed that prognostic understanding was associated with
poorer emotional well-being and more pain. We found no rela-
tionship between prognostic understanding and the other domains
of QoL, nor with mood. In contrast, more anxious and/or depres-
sive feelings were found to correlate with detrimental effects in the
different domains of QoL. Patients who were using positive
reframing as a coping strategy reported a better QoL.Table 4 Range, Number of Items, Median, Standard Deviation, and
Variable Range Items, n
General quality of life 0-100 1
Physical quality 0-100 3
Emotional well-being 0-100 2
Pain 0-100 2
Fatigue 0-100 2
Dyspnea 0-100 1
Insomnia 0-100 1
Loss of appetite 0-100 1
Constipation 0-100 1
Nausea 0-100 1
Abbreviations: NA ¼ not applicable; SD ¼ standard deviation.
- Clinical Lung Cancer May 2019A limited number of previous studies have explored the rela-
tionship between prognostic understanding and the QoL of patients
with advanced cancer. Three monocentric studies on prognostic
understanding and QoL were conducted by the same research group
from Massachusetts General Hospital (MGH).5-7 The investigators
showed that prognostic awareness was related to worse overall QoL
and mood. It is likely that their results differ from our results
because of differences in the methodological approach. Two main
differences have been discussed in the subsequent paragraphs.
First, the MGH investigators used the Functional Assessment of
Cancer TherapyeGeneral, version 4, questionnaire to measure
QoL. This questionnaire consists of 27 questions and combines
functional, physical, social, and emotional well-being. It is not clear
whether some or all of the speciﬁc domains of QoL were related to
prognostic understanding in these studies. In our study, prognostic
understanding was evaluated using 2 items: “I can be cured” and
“My treatment can cure me.” The response options were given
using a 4-point Likert scale, ranging from “very likely” to “not at all
likely.” Previous research has shown that prognostic understanding
measured using this method is valid and reliable in our patient
population.3 Patients who have obtained prognostic understanding
will choose QoL as goal of therapy signiﬁcantly more often statis-
tically than will patients who are not aware of the incurability of
their disease.
Second, the MGH studies used different terms for deﬁning
prognostic understanding, resulting in different outcomes for QoL
and mood. Of the MGH patients, 50% to 67% had prognostic
understanding, depending on how it was deﬁned.7 This is a high
proportion compared with that reported by other studies.3,13,14 The
use of the word “terminal” to deﬁne prognostic understanding
resulted in patients reporting a poorer QoL and mood.7 When
prognostic understanding was deﬁned as “knowing one cannot be
cured,” it did not correlate with poorer QoL or mood. Patients who
indicated that their doctors’ intention was not to cure them reported
poorer QoL and more anxiety. In the present study, we did not use
the term “terminal” because it refers to care at the end of life, in
contrast to “palliative,” which focuses on relieving pain rather than
treating the condition. Thus, the deﬁnitions of prognostic under-
standing are key and can make comparisons difﬁcult.
The results of the present study have conﬁrmed the ﬁndings from
earlier research conducted of patients with gastrointestinal cancer,5Cronbach’s a of the Different Dimensions of Quality of Life
Mean SD Cronbach’s a
61.29 19.4 NA
78.6 22.34 0.70
72.4 24.87 0.73
26.37 30.06 0.87
24.6 27.44 0.77
32.5 31.66 NA
33.3 34.93 NA
31.4 35.4 NA
14.6 27.7 NA
18.0 28.47 NA
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Annelies Janssens et alin which accurate prognostic understanding was associated with
lower QoL. Prognostic understanding was assessed using the ques-
tion “In your opinion, what is the chance that your cancer is
curable?” The answers were given using a 7-point Likert scale,
ranging from 0% (“no chance”) to >90% (“extremely high”).
Scores of 1 to 3 were considered to indicate prognostic under-
standing. Measured using this scale, prognostic understanding was
related to worse overall QoL and worse social and emotional well-
being. Mood did not correlate with prognostic understanding.
This measurement of prognostic understanding was similar to that
used in our study, with a similarity reﬂected in the results. Patients
who have described themselves as “terminally ill” (indicating that
they have prognostic understanding) have reported poorer QoL and
mood.5 In another study of patients with hematologic disease,
prognostic understanding was measured differently.6 One Chinese
study of 137 patients with epidermal growth factor receptor-
mutated lung cancer concluded that prognostic understanding will
be associated with poorer QoL and more anxiety and depressive
feelings.14 Prognostic understanding was determined using an
interview: patients were asked whether they could name their
disease. If the patient did not know that they had lung cancer, no
further questions were asked. If the patient was aware that they had
lung cancer, they were asked if their cancer could be cured. The
patients were then divided into 3 groups: fully aware, partially aware
(if only the diagnosis was known), and unaware. In that study, 21%
were found to be fully aware, 63% were anxious, and 72% had
depressive symptoms.15 More studies are needed to investigate the
inﬂuence of prognostic understanding on QoL in a range of
different patient populations.
An additional result of our study was that the patients had a
high psychological symptom burden, with 40% experiencing
anxiety or depressive feelings—the most important factors in
QoL. This ﬁnding was consistent with those from previous
studies.16,17 The questionnaire used in our study also showed that
a coping strategy, namely positive reframing, can positively in-
ﬂuence QoL in this patient population. This, too, has been re-
ported previously.18
The results from the present study have conﬁrmed the general
public’s perception that prognostic understanding is responsible for
lower QoL. Also, oncologists worry about damaging patients’
emotional well-being, which might explain why many admit to
withholding prognostic information.19,20 This seems a valid
concern, considering the data from our study. Communication with
patients regarding the palliative setting remains challenging.
Nevertheless, it is important to inform patients regarding the
palliative intent of the treatment from the beginning, despite its
effect on emotional well-being. The treating oncologist/pulmonol-
ogist should inform the patient of the bad news. This conversation
should be rehearsed, announced, and held had in the presence of the
patients’ caregivers and family in a calm environment. In most cases
when bad news is presented, a part of the message will not be
received. It will require time and several visits. Providing care as
treating physicians enables us to establish longitudinal relationships
with the patients and their families to help patients understand their
prognosis and make decisions about their care over time. In real life,
treating oncologists have tended to focus on treatment and “forget”
to talk about the prognosis.21Clinical Lung Cancer May 2019 - e373
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importance for informed decision-making and advanced care plan-
ning at the end of life. The results of our former study have
conﬁrmed this ﬁnding. Patients with prognostic understanding were
more aware of the primary goal of their palliative treatment. We
have concluded that it is beneﬁcial to inform such patients that
treatment cannot cure them, because this will lead them toward
other choices better suited for palliative treatment.3 The question
remains whether patients can be informed of the prognosis from the
diagnosis onward without detrimental effects on their QoL. It seems
that this is only possible if the necessary preconditions (ie, early
palliative care with holistic support of the patient and family) have
been met. The studies from Temel et al2 and Bakitas et al22 showed
that informing patients from the diagnosis with an integrated
holistic approach (early palliative care) will lead to a better Qol and,
even, better survival, in combination with better prognostic
understanding. Studies have found that the late implementation of
palliative care cannot fully improve patients’ QoL.23,24 Also, the
results from a real-world study have provided supporting evidence
that earlier palliative care will be associated with a greater process of
care quality score, predominantly driven by improvements in the
domain of information and care planning.25
In the present study, we sought to emphasize the importance of
informing patients of their palliative setting, provided that patients
are provided psychological and holistic support, as seen in early
palliative care. The key elements of early palliative care have been
provided in a prospective study, suggesting that palliative care
clinicians can help improve the QoL and mood outcomes in
patients with incurable cancer in part by enhancing effective coping
processes.26 Our study also showed that positive reframing as a
coping strategy has a positive effect on QoL. Further research is
needed to conﬁrm these promising results. Physicians must be
educated on how to improve their patients’ coping skills.
At present, it is not possible for all patients with advanced lung
cancer to be treated and/or counseled on a regular basis by a
psychologist in our hospital. We plan to measure anxiety and
depressive feelings using the HADS questionnaire during ﬁrst-line
chemotherapy. Patients with higher scores than normal (4 of 10
in our study) will be referred for psychological evaluation. This
workload seems achievable for the psychologist. Our team believes
that informing patients about the palliative setting remains impor-
tant despite its negative effects on well-being. A holistic approach
with psychological support seems mandatory when treating patients
with advanced lung cancer to overcome this deterioration of QoL.
All team members must be expected to allow for some time for
psychological support during visits.27
The present research had limitations related to cross-sectional
investigations. First, the patients completed the questionnaires
only once. If another time frame had been chosen, it might have
provided other results. Because no comparisons were made over
time, causality could not be evaluated. Second, only 3 patients were
not willing to complete the questionnaires. This was a very low
screening failure rate, indicating a possible bias, because only
patients who were already communicating openly about their
prognosis were asked to participate. In addition, we found no
reference standard for measuring prognostic understanding, which
has hindered research on this important topic.- Clinical Lung Cancer May 2019Conclusion
Patients who possess prognostic understanding will have poorer
emotional well-being and more pain. Prognostic understanding was
not associated with more anxiety or depressive feelings. The QoL of
patients with advanced lung cancer will be especially inﬂuenced by
their mood. Approximately 40% of patients will be anxious or have
depressive feelings. Patients with advanced lung cancer require
psychological support, not only when proposing the palliative
setting, but also to ameliorate their mood, perhaps through the
teaching of more favorable coping strategies. The “positive refram-
ing” coping strategy improved the QoL of patients with advanced
lung cancer. In the future, we plan to conduct a prospective study to
investigate whether favorable coping strategies can be taught and
whether they have an effect on QoL.
Clinical Practice Points
 To the best of our knowledge, ours is the ﬁrst European study to
investigate the relationship between prognostic understanding
and QoL in patients with advanced lung cancer.
 Our results have shown that prognostic understanding is asso-
ciated with poorer emotional well-being and more pain but not
with a worse mood.
 The QoL of patients with advanced lung cancer is especially
inﬂuenced by their mood.
 Approximately 40% of patients will have anxious or have
depressive feelings.
 Patients who were using positive reframing as a coping strategy
reported a better QoL.
 Patients with advanced lung cancer require psychological sup-
port, not only when proposing the palliative setting, but also to
ameliorate their mood, perhaps through the teaching of more
favorable coping strategies.Disclosure
The authors declare that they have no competing interests.References
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